Source - LSE Regulatory
RNS Number : 2662Y
Hikma Pharmaceuticals Plc
29 July 2024
Hikma Pharmaceuticals PLC
Director Declaration
LONDON, 29 July 2024: Pursuant to Listing Rule 9.6.14, Hikma Pharmaceuticals PLC confirms that Victoria Hull, Senior Independent Non-Executive Director, has been appointed as a Non-Executive Director of IMI plc with effect from 1 August 2024.
- ENDS -
Enquiries:
| Hikma Pharmaceuticals PLC | |
| Helen Middlemist Group Company Secretary | +44 20 7399 2760 |
Hikma Pharmaceuticals PLC (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY)
(LEI: 549300BNS685UXH4JI75)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
